Dr Pierluigi Costanzo

Dr Pierluigi Costanzo is an experienced  consultant cardiologist  practicing in  Cambridge  at  Royal Papworth Hospital,  leading heart and lung hospital in the UK, where he also serves as the clinical lead for coronary intervention. He also practices at the  Nuffield Health Cambridge Hospital . Dr Costanzo has vast experience in the field of  general cardiology  and  interventional  &  structural cardiology. He has a large experience in dealing with common heart-related issues ( angina  or  chest tightness ,  shortness of breath ,  palpitations ,  dizzy spells ,  blackouts ). He also undertakes a broad range of  key-hole heart interventions , including  coronary  (heart arteries)  angioplasty  and  stent  to relieve angina and provide improved blood flow to the heart muscle. He is a leading cardiologist also in key-hole treatments of  heart valve problems  (particularly for the aortic valve, for which he performs “ TAVI ” procedures to replace damaged aortic valves).  Before starting his consultant post at  Royal Papworth Hospital , he spent one year at  Toronto General Hospital (Canada)  to train in  complex coronary intervention , having been awarded the competitive British Cardiovascular Intervention Society training grant. Following that, he was appointed as a structural (heart valves and structure) interventional fellow for one year at St Michael’s Hospital (Toronto, Canada). During this time he trained in  TAVI and other structural procedures, having also the opportunity to participate in several pioneering heart valve procedures. He graduated with first-class honour and academic  distinction  from medical school in Italy and then moved to England where he undertook training in general internal medicine, cardiology, and interventional cardiology East Yorkshire, mainly working at Castle Hill Hospital  (Cottingham).  During this time he also obtained  a   Master   of   Science   (MSc)   and   Doctor   of   Medicine   (MD) research degrees from the University of York, focusing on prevention of cardiovascular events,  particularly in diabetic patients. He published several high-impact research articles and won multiple investigator awards at the European Society of Cardiology and American College of Cardiology conferences.